SGLT2 inhibition eliminates senescent cells and alleviates pathological agingGoro Katsuumi, Tohru Minamino, Yohko Yoshida et al.|Nature Aging|2024Cited by 132
Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and DesignTohru Minamino, Shinya Fujiki, Kenichi Iijima et al.|Diabetes Therapy|2020Cited by 21